What is the optimal medication regimen for a patient with severe anxiety and panic attacks who is currently taking amitriptyline 75 mg, bupropion (Wellbutrin) extended‑release 300 mg (which worsens anxiety), buspirone 30 mg twice daily, zolpidem (Ambien) 10 mg nightly (ineffective), and alprazolam (Xanax) 1 mg twice daily, has failed multiple SSRIs and other agents, and prefers treatments with minimal weight gain and sexual side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinue Bupropion Immediately and Optimize Amitriptyline-Based Regimen

The optimal approach is to discontinue bupropion (which is worsening her anxiety), continue amitriptyline 75 mg (which was working well), continue buspirone 30 mg twice daily, and address the insomnia with a non-benzodiazepine approach while working toward gradual benzodiazepine taper. 1, 2

Immediate Medication Changes

Stop Bupropion

  • Discontinue bupropion extended-release 300 mg immediately. Bupropion is explicitly contraindicated in agitated patients and is known to worsen anxiety and cause insomnia 1, 3. The evidence shows bupropion's stimulating properties can provoke anxiety, particularly at higher doses, and while it may help some depressed patients with mild anxiety, it clearly exacerbates severe anxiety and panic 3. Given that it's causing "increasing anxiety and agitation" in this patient, continuing it is counterproductive.

Continue and Optimize Current Effective Agents

  • Maintain amitriptyline 75 mg nightly. This was working well for her anxiety before the problematic medication changes. Tricyclic antidepressants are effective for anxiety disorders, particularly when associated with insomnia 1. Amitriptyline's sedating properties also address sleep issues 1.

  • Continue buspirone 30 mg twice daily. Buspirone is effective for generalized anxiety disorder and has minimal weight gain or sexual side effects 1, 4. While it may take 2-4 weeks to reach full effectiveness 1, it aligns with her preference profile and can augment the amitriptyline.

Address the Insomnia Problem

Replace Zolpidem

Zolpidem (Ambien) 10 mg is ineffective and should be replaced. 5, 6 The insomnia guideline explicitly states that when initial treatment is ineffective, other therapies should be considered 5.

Switch to trazodone 25-50 mg at bedtime, which can be titrated up to 200-400 mg as needed 1. Trazodone is:

  • Effective for insomnia in anxious patients
  • Sedating without benzodiazepine risks
  • Particularly useful when combined with other antidepressants 1
  • Has minimal sexual side effects or weight gain
  • Can augment amitriptyline's anxiolytic effects

Benzodiazepine Management

Critical Issue with Current Alprazolam Use

Alprazolam (Xanax) 1 mg twice daily represents a significant long-term risk 2. The FDA label explicitly warns about dependence, withdrawal, and the need for gradual taper 2. However, given her extensive medication failures and severe anxiety, do not attempt immediate discontinuation.

Short-term plan (next 2-3 months):

  • Continue alprazolam 1 mg twice daily while optimizing other medications
  • Once amitriptyline + buspirone + trazodone regimen is stable and anxiety is controlled, begin very gradual taper
  • Reduce by no more than 0.25 mg every 2-3 weeks 2
  • Some patients may require even slower tapers 2

The guideline evidence supports benzodiazepines for anxiety but emphasizes they should be used infrequently at low doses due to tolerance, addiction, depression, and cognitive impairment risks 1. The research shows alprazolam is highly effective for panic disorder 7, but long-term use carries substantial risks 2.

Why This Regimen Addresses Her Priorities

Minimal sexual side effects:

  • Amitriptyline: Lower risk than SSRIs
  • Buspirone: Minimal sexual dysfunction
  • Trazodone: Minimal sexual side effects
  • This combination avoids SSRIs/SNRIs which caused her sexual side effects

Minimal weight gain:

  • Amitriptyline: Some weight gain possible but at 75 mg likely manageable
  • Buspirone: Weight neutral
  • Trazodone: Weight neutral
  • Avoids mirtazapine (significant weight gain) and atypical antipsychotics

Monitoring and Follow-up

Week 1-2:

  • Assess anxiety and agitation after bupropion discontinuation
  • Evaluate sleep with trazodone
  • Monitor for any withdrawal from bupropion (though typically minimal)

Week 4-6:

  • Assess full buspirone effect (requires 2-4 weeks) 1
  • Evaluate overall anxiety control
  • Adjust trazodone dose if sleep remains problematic

Month 3 onward:

  • If anxiety well-controlled, begin alprazolam taper
  • Continue monitoring for anxiety recurrence
  • Maintain amitriptyline + buspirone long-term

Critical Pitfalls to Avoid

  1. Do not add another SSRI or SNRI - She has failed multiple agents in these classes with poor tolerability 8, 9, 8

  2. Do not use hydroxyzine - Already tried and "just made her sleepy, didn't work for anxiety" 1

  3. Do not add atypical antipsychotics yet - Reserve quetiapine or others for refractory cases after optimizing this regimen 1, 10

  4. Do not abruptly stop alprazolam - Risk of life-threatening withdrawal 2

  5. Do not continue bupropion - It is explicitly contraindicated in agitated patients 1

Alternative if This Fails

If after 8-12 weeks this regimen provides inadequate response:

Consider adding pregabalin 150-300 mg/day 11, 10, 12:

  • Effective for generalized anxiety disorder
  • Minimal sexual side effects
  • Weight neutral to mild weight gain
  • Can be combined with current regimen
  • Start 75 mg twice daily, titrate to 150 mg twice daily over 1-2 weeks

Or consider switching to venlafaxine XR 75-225 mg/day 8, 11, 4:

  • Despite being an SNRI (which she hasn't tried), venlafaxine has strong evidence for both GAD and panic disorder
  • More effective than buspirone in head-to-head trials 4
  • Sexual side effects less than SSRIs but still present
  • Requires blood pressure monitoring 11

This evidence-based approach prioritizes her quality of life by addressing the medication causing harm (bupropion), optimizing what was working (amitriptyline), and adding complementary agents (buspirone, trazodone) that match her side effect preferences while planning for eventual benzodiazepine reduction.

References

Research

Bupropion and Anxiety: A Brief Review.

Human psychopharmacology, 2025

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Pharmacological treatments in panic disorder in adults: a network meta-analysis.

The Cochrane database of systematic reviews, 2023

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.